Tetrabutylammonium Fluoride → HCID 86708501, compound
Reaction equation
CCCC[N+](CCCC)(CCCC)CCCC.[F-].[Cl:19][C:20]1[C:25]([NH:26][C:27]2[N:32]=[C:31]([NH:33][CH:34]3[CH2:36][CH2:35]3)[C:30]3=[N:37][CH:38]=[C:39]([C:40]#[N:41])[N:29]3[N:28]=2)=[CH:24][C:23]([C:42]#[N:43])=[CH:22][C:21]=1[N:44]1[CH2:49][CH2:48][C@@H:47]([NH:50][S:51]([CH3:54])(=[O:53])=[O:52])[C@H:46]([O:55][Si](C(C)C)(C(C)C)C(C)C)[CH2:45]1>C1COCC1>[Cl:19][C:20]1[C:25]([NH:26][C:27]2[N:32]=[C:31]([NH:33][CH:34]3[CH2:35][CH2:36]3)[C:30]3=[N:37][CH:38]=[C:39]([C:40]#[N:41])[N:29]3[N:28]=2)=[CH:24][C:23]([C:42]#[N:43])=[CH:22][C:21]=1[N:44]1[CH2:49][CH2:48][C@@H:47]([NH:50][S:51]([CH3:54])(=[O:53])=[O:52])[C@H:46]([OH:55])[CH2:45]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
TBAF (1M in THF, 0.048 mL, 0.048 mmol) was added to a solution of N-((3R,4R)-1-(2-chloro-5-cyano-3-((7-cyano-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-((triisopropylsilyl)oxy)piperidin-4-yl)methanesulfonamide (28 mg, 0.040 mmol) in THF (2 mL) and the reaction mixture was stirred at room temperature overnight. Solvent was evaporated and the crude product was purified by flash chromatography on silica gel using an automated ISCO system (12 g column, eluting with 0-6% methanol/dichloromethane). N-((3R,4R)-1-(2-chloro-5-cyano-3-((7-cyano-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-hydroxypiperidin-4-yl)methanesulfonamide (21 mg) was obtained as a white solid.
Workup
- customSolvent was evaporated
- customthe crude product was purified by flash chromatography on silica gel using
- washan automated ISCO system (12 g column, eluting with 0-6% methanol/dichloromethane)
Sources & evidence
- ORD record
- ord-706c9c75586c4f4ea51272bbd742989e
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09273057B2
Reaction notes
Loading…